🟡 70/100

Review before taking

  • Niacin: 45mg is 1.3× the Tolerable Upper Intake Level (35mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 50% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Niacin: 45mg is 1.3× the Tolerable Upper Intake Level (35mg)
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

The product's niacin level exceeds the recommended maximum daily limit, and it uses a proprietary blend that does not disclose the exact amounts of all ingredients.

Label Data

1 mL Serving Size
30 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

45 mg (225% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.3× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 45mg UL 35mg
Proprietary Blend containing
261 mg

Other Ingredients

Water Glycerin Sorbitol Sucralose Natural Flavors and Artificial Flavors Lactic Acid Sorbic Acid Sodium Benzoate Xanthan Gum

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

DIRECTIONS: Adults take one dropperful (1 mL) by mouth twice daily before meals. Do not exceed 2 servings per day. Shake well before use. Refrigerate after opening.

⚠️ Warnings & Precautions

Keep out of reach of children.

Not for use by individuals under the age of 18 years. Do not use if pregnant or nursing.

Consult your physician before use if you are sensitive to stimulants.

Do not purchase if seal is broken.

Niacin (vitamin B3) may cause temporary skin flushing, redness or itching in those persons who are sensitive to niacin. If they occur, these temporary side effects will subside in a matter of minutes. Do not exceed suggested daily serving.

NOTE: Limit the use of caffeine-containing medications, foods or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness and occasionally, rapid heart beat. For additional information on this product, please call our experienced customer service representatives at: 1-800-898-5153.

WARNING: This product contains a significantly potent xanthine (i.e., caffeine and caffeine-like stimulants) mixture, of about 100 mg per serving.

Additional Information

Protect from heat, light, and moisture. Store at controlled room temperature: 15°-30°C/59°-86°F

††In a published, randomized, double-blind, placebo-controlled clinical study, 48 obese and overweight participants were divided into 2 groups, and were told to take either the active compound or a placebo before 2 main meals, with an 8-ounce glass of water. No major dietary changes nor exercise were suggested during the study. During the 10-week study, the group that took the active compound showed an average of 14.6% body fat lost and an average of 19.4 pounds lost without any major changes in diet or exercise. However, it is always advisable to engage in a sensible diet and exercise program.

©2011 All Rights Reserved

Active compound shown to influence the cellular dynamics of adipose (fat) cell metabolism.*

Advanced Liquid Fat Burning* Drops

BR13740-3

Clinically shown to significantly decrease body fat by an average of 14.6% in a matter of weeks*††

DSG-072806-213

Fat Burning* Energy*

If you or your health care provider have any questions, please call: 1-800-898-5153.

Individual results may vary.

International distribution is not authorized without prior written consent. Product resale allowed only through authorized representatives.

This product is manufactured to be within all acceptable industry variances.

Use in conjunction with any sensible diet and weight loss program.

Use only as directed.

Product Details

UPC / SKU 8 56528 00118 6
DSLD Entry Date 2011-11-25
Product Type Other Combinations
Form Liquid
DSLD ID 2121
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →